"After the Sale"

Tuesday, September 20, 2022
Zoom Set Up 8:45 AM | Meeting 9:00-11:00 AM

This time last year, several ABL Members shared with us they were "headed for the exit." Since then, eight Members have either sold their entire company or a majority position in it. Among them, three - representing sales to a public company, a heavily financed startup, and a private equity firm - have reaped the benefits (and a few thorns) that were on their "Roads to the Exit." During this webinar, you'll hear from each presenter: What's Worked Better (and Worse) Than Expected, and What They'd Do Differently Next Time. They'll also Answer Your Questions about their "processes," because you're bound to have a few!

Bob Richardson Sumit Mahendru Thomas Leffler
Bob Richardson, formerly CEO, VCP - now President, VCP, a Covectus Solution for pet care Sumit Mahendru, formerly CEO, Savi Group - then Head of RCM, Athelas; now CEO, Abstrakt Health Thomas Leffler, President, RE Pharmacy - now selecting among several "NEXT" opportunities

Bob Richardson is the consummate entrepreneur. Since 1992, he's built six different businesses, the last several of which evolved from BillWise, which provided carrier-grade customer care and billing solutions for cable, cellular, and utility companies. Becoming an expert in billing, Bob applied his tech and marketing savvy to creating VCP, a company that became the leading provider of wellness, chronic disease, and lifestyle membership plans for pets and the leading SaaS solutions in the veterinary market. About a year ago, publicly traded Covetrus, an animal health leader, acquired VCP. Bob is still there.

Sumit Mahendru was a tech savant hired by SAVI Group six years ago to grow the company. Not only did Sumit double SAVI’s revenues and clients served - he did it without adding staff to their operations in the U.S. or India, becoming CEO in the process. Then, last December, Athelas, which monitors the chronically-ill - and had recently raised $132 million from Sequoia, NVIDIA, and YCombinator (at a $1.5 billion valuation), bought SAVI for its Revenue Cycle Management platform, and tapped Sumit to head the new division. Recently Sumit left Athelas making his startup, Abstrakt Health, his full-time focus.

Thomas Leffler was also recruited by the founders to restructure, turnaround, grow, and ultimately position Rivers Edge Pharmacy for a successful sale. During his tenure leading RE Pharmacy, it grew into a major regional specialty pharmacy and infusion services company. RE was licensed in 19 states with 10 infusion centers. Thomas concurrently co-founded a RE sister company with a disruptive telemedicine platform, Next eHealth. His success at RE was facilitated by having turned around several companies in different industries over his career. No wonder he took a break after RE - which is just about to end.

RSVP today for this very special event - that's included at no additional charge in your ABL Healthcare or Technology Membership!

Laura Grant, Director, Member Services & Events
Laura@abl.org | www.ABLOrg
20232 Morristown Cir., Huntington Beach, CA 92646